QIAGEN to Acquire Parse Biosciences

Parse Biosciences Acquires Biomage

January 16, 2024

Software

Parse Biosciences has acquired data analysis software company Biomage, integrating Biomage's cloud-based single-cell RNA sequencing analysis platform into Parse's product portfolio. The deal will give Parse customers access to faster, intuitive single-cell data analysis (Biomage's Cellenics/Cellscope), pairing Parse's Evercode combinatorial barcoding technology with Biomage's analysis tools to reduce analysis time and expand capabilities.

Paragon Group Acquires Parseq Limited

February 13, 2026

Professional Services

Paragon Group has acquired Parseq Limited, a UK-based specialist in document, finance, and payment process automation, to strengthen its business process services capabilities. The deal (which includes 354 employees globally) is intended to expand Paragon's UK footprint, accelerate innovation by integrating Parseq's robotic process automation and machine learning capabilities, and secure intellectual property for financial services clients.

QIAGEN Acquires Verogen

January 9, 2023

Biotechnology

QIAGEN completed the acquisition of Verogen for $150 million in cash, bringing Verogen’s NGS-based human identification and forensic genomics products and the GEDmatch database into QIAGEN’s forensics portfolio. The deal gives QIAGEN exclusive distribution rights for the MiSeq FGx forensic sequencer version and is intended to expand QIAGEN’s capabilities and commercial footprint in the fast-growing Human ID/forensics market.

CellCarta Acquires Biogazelle

December 14, 2021

Biotechnology

CellCarta has acquired Biogazelle, a Ghent-based leader in digital PCR (dPCR), qPCR and RNASeq assay development, to strengthen and expand its genomic capabilities. The acquisition creates a Center of Excellence for complex genomic biomarker assay development within CellCarta and broadens its service offering for pharmaceutical and biotech clients across discovery and clinical stages.

10x Genomics to Acquire Scale Biosciences

August 7, 2025

Healthcare Services

10x Genomics, Inc. has signed a definitive agreement to acquire Scale Biosciences, Inc., a single-cell analysis company. The deal is intended to expand 10x’s Chromium platform with Scale’s key inventions and technologies and broaden access to scalable single-cell analysis for researchers worldwide.

Agilent Technologies to Acquire Biocare Medical for $950 Million

March 9, 2026

Healthcare Services

Agilent Technologies entered into a definitive agreement to acquire Biocare Medical, a global provider of clinical and research pathology solutions, in an all-cash transaction valued at $950 million. The deal is designed to expand Agilent’s pathology portfolio—especially immunohistochemistry—and is expected to close no later than Agilent’s fourth fiscal quarter of 2026.